HTTP Strict Transport Security

TrustFour Scan of Fortune 500 Uncovers Seven Deadly Sins of TLS Configuration Non-Compliance Against NIST 800-52R

Retrieved on: 
Tuesday, September 26, 2023
NIST, Pressure, TLS, Transport, Certificate authority, Intelligence, IETF, Research, Risk, Privacy, Government, Organization, TLS 1.0, MAC, R2, National Institute of Standards and Technology, CBC, OCSP, SAN, HTTP Strict Transport Security, News, Roald Amundsen, Cargo, Internet service provider, Audit, Television

In its report titled, “State of TLS Boundary Compliance Report,” TrustFour uncovered several trends that make up the “seven deadly sins” of TLS configuration non-compliance against the National Institute of Standards and Technology (NIST) 800-52 R2 standard.

Key Points: 
  • In its report titled, “State of TLS Boundary Compliance Report,” TrustFour uncovered several trends that make up the “seven deadly sins” of TLS configuration non-compliance against the National Institute of Standards and Technology (NIST) 800-52 R2 standard.
  • “TLS configuration is a mission-critical aspect of reducing the attack surface for any organization, ensuring data-in-transit data integrity and privacy.
  • We will scan the Fortune 500 twice a year and provide the public with the results.”
    TrustFour’s State of TLS Boundary Compliance Report, analyzed the security and compliance of nearly 120,000 domains across Fortune 500 companies.
  • The good news is 80% of the Fortune 500 can achieve NIST compliance with just 7 straight forward configuration changes.

BreachLock's Intelligence Report reveals rare industry insights from over 8,000 PenTests

Retrieved on: 
Tuesday, June 28, 2022
Efficiency, Security, CEO, Human, HTTP Strict Transport Security, Intelligence, A.I, James Cullen (PTAA), Ecosystem, High, Critical, CISO, Scale, Software as a service, Penetration test, Comprehensive, Communication, Workflow, Artificial intelligence, Non-functional testing, NEW, AI, Operation, Collection, Medical device, Service, Automation, HSTS

NEW YORK, June 28, 2022 /PRNewswire/ -- BreachLock, a unified Penetration Testing as a Service (PTaaS) platform that caters to enterprise penetration testing needs is releasing its maiden version of "Annual Penetration Testing Intelligence Report, 2022".

Key Points: 
  • NEW YORK, June 28, 2022 /PRNewswire/ -- BreachLock, a unified Penetration Testing as a Service (PTaaS) platform that caters to enterprise penetration testing needs is releasing its maiden version of " Annual Penetration Testing Intelligence Report, 2022 ".
  • BreachLock has been helping clients with Penetration Testing as a Service since 2019 and delivers its services using a SaaS platform.
  • "Today I feel extremely proud of my team to share the intelligence and conclusions that we have captured in the past 3.5 years.
  • The platform helps enterprise clients with Penetration Testing with the use of A.I (Artificial Intelligence)., Automation, and in-house PenTesters.

Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update

Retrieved on: 
Monday, May 16, 2022
DSO, U.S. Securities and Exchange Commission, Webcast, Review, Investor relations, Chief Dental Officer (Canada), Center, Risk, Securities Act of 1933, SEC, Tissue, Physician, Income, Obstructive sleep apnea, Social media, Protocol, Therapy, Marketing, PAP, Research, Patent, Medicare, The Center, HTTP Strict Transport Security, HST, Growth, Aircraft, Apnea–hypopnea index, GLOBE, Wane, Company, VIP, Snoring, Patient, Program, Congress, Securities Exchange Act of 1934, MD, Security (finance), Sleep apnea, NASDAQ, Very important person, Â, Industry, AHI, Eastern Time Zone, Dentist, Technology, SEC filing, CEO, Medical device, Video game, Pharmaceutical industry, Medical imaging, Appliance, Vivos

HIGHLANDS RANCH, Colo., May 16, 2022 (GLOBE NEWSWIRE) --  Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, today reported financial results and operating highlights for the first quarter ended March 31, 2022.

Key Points: 
  • Vivos has also trained over 1,500 dentists in the use of The Vivos Method and Vivos related value-added services, compared to just over 1,200 as of the first quarter of 2021.
  • In January 2022, Vivos announced an 18X increase in home sleep tests performed by Vivos-trained dentists in the fourth quarter of 2021 versus the fourth quarter of 2020.
  • Also in January 2022, Vivos filed a U.S. patent application related to certain new and enhanced clinical methods and protocols developed within Vivos proprietary Vivos Method treatment for OSA.
  • The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using The Vivos Method.

Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update

Retrieved on: 
Thursday, March 31, 2022
Method, Therapy, Congress, Sleep apnea, Adult, Research, SEC, CEO, HST, Securities Exchange Act of 1934, Securities Act of 1933, AHI, GLOBE, HTTP Strict Transport Security, Snoring, Annual report, Huntsman, Security (finance), Marketing, Aircraft, Risk, SEC filing, Investor relations, Health, Tissue, DSO, Omicron, U.S. Securities and Exchange Commission, Income, Health Canada, NASDAQ, Patent, Growth, Program, Webcast, Protocol, Data analysis, PDAC, Review, Center, Obstructive sleep apnea, DSOS, Drug Quality and Security Act, Awareness, Social media, Patient, Adoption, Apnea–hypopnea index, Company, Eastern Time Zone, Dentist, Very important person, COVID-19, VIP, Intelligence, Medical device, Pharmaceutical industry, Lithium, Animal, Video game, Medical imaging, Vivos, Medicare, Coding, Appliance

HIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, today reported financial results and operating highlights for the fourth quarter and full year ended December 31, 2021.

Key Points: 
  • Vivos has also trained over 1,450 dentists in the use of The Vivos Method and Vivos related value-added services, compared to just approximately 1,250 as of the fourth quarter of 2020.
  • In January 2022, Vivos filed a U.S. patent application related to certain new and enhanced clinical methods and protocols developed within Vivos proprietary Vivos Method treatment for OSA.
  • We also completed official registration of Vivos products with Health Canada, providing Canadian dentists complete access to Vivos services and products.
  • During the fourth quarter, we launched the Vivos sleep management program for DSOs, a marketing and sales initiative whose demand has already exceeded our expectations.

Magellan Healthcare Debuts Sleep Health Solution

Retrieved on: 
Wednesday, March 9, 2022
Biotechnology, Practice Management, Managed Care, Health, General Health, Pharmaceutical, Mental Health, Other Science, Research, Science, Clinical Trials, Hypertension, Degenerative disease, Sleep-related breathing disorder, Sleep apnea, National Sleep Foundation, Federation, OSA, Department, Ferdinand Magellan, Health, Diagnosis, Diabetes, Magellan Health, Sleep, Depression, Comorbidity, Risk, Trade, Hospital, Patient, Mental health, Obstructive sleep apnea, Treatment, Stroke, Solution, Technology, Health care, Anxiety, HTTP Strict Transport Security, Algorithm, Department of Defense Serum Repository, Medicine, Pharmaceutical industry, Magellan Healthcare, Magellan Health:, MAGELLAN HEALTHCARE, MAGELLAN HEALTH:

Magellan Healthcare , the behavioral health and specialty division of Magellan Health, Inc. , today announced the release of its new Sleep Health solution for payers, which is designed to ensure members get the right test at the right time through the use of sophisticated clinical intake algorithms and decision support that reduces clinical variation and repeat testing.

Key Points: 
  • Magellan Healthcare , the behavioral health and specialty division of Magellan Health, Inc. , today announced the release of its new Sleep Health solution for payers, which is designed to ensure members get the right test at the right time through the use of sophisticated clinical intake algorithms and decision support that reduces clinical variation and repeat testing.
  • ET: Join the Magellan Healthcare webinar, Obstructive Sleep Apnea: Impacts, Diagnosis and Treatment, with board-certified neurologist and somnologist, Dr. Karen Jablonski, physician clinical reviewer, Magellan Healthcare, and board-certified psychologist, Jamie Hanna, M.D., medical director, Magellan Healthcare, as they address the impacts of OSA on our physical and mental health and OSA diagnosis and treatment.
  • About Magellan Healthcare: Magellan Healthcare, Inc. , the healthcare business unit of Magellan Health, Inc., offers solutions for complex conditions in the areas of behavioral health and medical specialty treatment.
  • About Magellan Health: Magellan Health, Inc. , is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare.

Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology

Retrieved on: 
Wednesday, January 19, 2022
Securities Exchange Act of 1934, Patient, Technology, Fibromyalgia, Birth, Stroke, CPA Practice Advisor, Risk, HST, SEC, Very important person, Sleep apnea, Adult, NASDAQ, Securities Act of 1933, CEO, Obstructive sleep apnea, GLOBE, Chronic pain, OSA, U.S. Securities and Exchange Commission, Tissue, Heart failure, Dentist, Apnea–hypopnea index, Therapy, Program, Diabetes, Conditional sentence, HTTP Strict Transport Security, CPAP, Prevalence, Science and technology in Asia, Drug Quality and Security Act, VIP, Snoring, Security (finance), Dementia, Pharmaceutical industry, Vivos

HIGHLANDS RANCH, Colo., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (OSA) and snoring, today announced significant increases across several key metrics for its SleepImage Home Sleep Apnea Tests (HST).

Key Points: 
  • Under the new revenue model with SleepImage, Vivos will lease out the SleepImage ring recorders to Vivos trained dentists at a fixed price that includes a full months worth of diagnostic sleep test reports.
  • Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from mild-to-moderate obstructive sleep apnea (OSA).
  • Vivos also markets and distributes SleepImage diagnostic technology, powered by VivosScore for Home Sleep Testing in adults and children.
  • The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using the Vivos System.

Accelerated Digital Transformation Driving Rapid Adoption of Secure Internet Protocols, But Falling Short in Adoption of Stronger Key Algorithms

Retrieved on: 
Thursday, December 9, 2021
Software, Technology, Internet, Security, Transfer, Cloud, App Store (iOS/iPadOS), Acceleration, CA, Certificate, Research, API, SSH, Automation, EV, ECDSA, SSL/TLS, Venafi, MTL, HSTS, RSA, Transport Layer Security, DSA, Transport layer, Internet, Bombardier Global Express, Secure Hypertext Transfer Protocol, Intelligence, Organization, HTTPS, Adoption, IOT, TLS, SSL, Government, HTTP Strict Transport Security, Cloudflare, Communication, Algorithm, Cryptocurrency, Online shopping, Cargo, Computer data storage

Driven by the acceleration of digital transformation and cloud migration during the pandemic, the analysis shows that in many ways, the internet is becoming more secure.

Key Points: 
  • Driven by the acceleration of digital transformation and cloud migration during the pandemic, the analysis shows that in many ways, the internet is becoming more secure.
  • 72% of sites now actively redirect traffic to use HTTPS (Hypertext Transfer Protocol Secure)a 15% increase since March 2020.
  • RSA continues to be preferred in digital signature algorithms, with 50.47% of sites using it.
  • Of the three categories of key generation algorithms commonly used for asymmetric encryption RSA, DSA and ECDSA ECDSA is the most secure due to the computational complexity.

Tala Security Broadens Its Reach With Cloudflare Integration

Retrieved on: 
Thursday, March 5, 2020
Internet, Security, Data management, Technology, Software, Computer security, Computing, Computer networking, Internet security, Computer network security, Hacking, Cloudflare, Content Security Policy, HTTP Strict Transport Security, Subresource Integrity, Security controls, Tala Security, Cloudflare

The Tala security module on Cloudflare assures website protection with near-zero impact on performance.

Key Points: 
  • The Tala security module on Cloudflare assures website protection with near-zero impact on performance.
  • Tala partnered with Cloudflare to further the shared goals of ensuring website security, preserving data privacy and assuring the integrity of web commerce.
  • Cloudflare helps form the foundation of the modern web, said Tala Security founder and CEO Aanand Krishnan.
  • Tala defends against such attacks by automating the deployment and dynamic adjustment of browser-native, standards-based security controls such as Content Security Policy (CSP), Subresource Integrity (SRI), HTTP Strict Transport Security (HSTS) and other web security standards.